SIGN UP
LOG IN
MARKET
PAHC
PAHC
Phibro Animal
NASDAQ
9.87
+0.28
+2.92%
After Hours: 9.87 0 0.00% 16:03 12/01 EST
OPEN
9.62
PREV CLOSE
9.59
HIGH
10.02
LOW
9.50
VOLUME
495.82K
TURNOVER
0
52 WEEK HIGH
16.52
52 WEEK LOW
9.29
MARKET CAP
399.77M
P/E (TTM)
19.28
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at PAHC last week (1120-1124)?
Weekly Report · 11/27 10:57
Phibro Animal Health's Ex-Dividend Date Is Tuesday, Here's What You Need To Know
Phibro animal health announced on monday that it will pay shareholders a quarterly dividend of 12 cents per share. The company will go ex-dividend on tuesday. Phibro's stock will likely open 12 cents lower on that date. The next dividend will be paid out to shareholders on december 20, 2023.
Benzinga · 11/23 14:45
Phibro Animal Health: Vaccine App And Analysts' Expectations Imply Undervaluation
Phibro animal health corporation is expected to experience net sales growth and net income growth in the coming years. The company has a healthy balance sheet with little debt, and is undervalued. Phibro did not surprise the market in the last quarterly earnings release. There are risks from changing regulations and competition, but the company appears to be on the right track.
Seeking Alpha · 11/21 01:53
Weekly Report: what happened at PAHC last week (1113-1117)?
Weekly Report · 11/20 10:55
Weekly Report: what happened at PAHC last week (1106-1110)?
Weekly Report · 11/13 10:49
Underperform Rating for Phibro Animal Health: Analysis of Q1 Results and Future Challenges
TipRanks · 11/10 12:32
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Astra space, inc. Shares climbed 59.5% to $1.18 after astra received a non-binding proposal to acquire all of the company's stock. The honest company shares rose 23% following upbeat quarterly results. Affirm holdings shares rose 22.7% after reporting better-than-expected first-quarter results.
Benzinga · 11/09 18:13
What 4 Analyst Ratings Have To Say About Phibro Animal Health
In the last 3 months, 4 analysts have offered 12-month price targets for phibro animal health. The company has an average price target of $18.75 with a high of $21.00 and a low of $16.00. Analysts have provided ratings for the company in the last quarter. The greater the number of bullish ratings, the more positive analysts are on the stock.
Benzinga · 11/09 17:00
About PAHC
Phibro Animal Health Corporation is a diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 770 product lines in over 80 countries to approximately 4,000 customers. The Company has three segments. Animal Health segment develops, manufactures and markets about 270 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. Mineral Nutrition segment manufactures and markets approximately 420 formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries, predominantly in the United States.
Webull offers Phibro Animal Health Corp stock information, including NASDAQ: PAHC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PAHC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.
You can practice and explore trading PAHC stock methods without spending real money on the virtual paper trading platform.